Semaglutide is linked to a reduced risk for Alzheimer’s disease-related dementia in patients with diabetes vs other antidiabetic drugs, a new study suggests.

More than one million donated drugs risk expiring within nine months due to deep cuts in global aid, threatening treatment programmes for neglected tropical diseases in Africa.

A new study published in the Journal of Alzheimer’s Disease has found that the active ingredient in popular drugs like Ozempic and Wegovy may lower the risk of developing dementia. NBC News ...

A new study from Case Western Reserve School of Medicine suggests that GLP-1 weight loss drugs like Ozempic and Wegovy could lower your risk of developing dementia.

Downloadable template of RASCI (Responsible, Accountable, Support, Consulted, Informed) assessment. Taken from appendix A of the Quality impact assessment framework above.